STAT

WHO readies to test Merck’s experimental Ebola vaccine in Congo outbreak

During a 2015 clinical trial in Guinea, a woman receives a vaccine against the Ebola virus.

It is looking like Merck’s Ebola vaccine may be about to get field-tested.

The World Health Organization said Friday it is putting everything in place to be able to use the experimental vaccine to help extinguish a worrisome outbreak in a remote area in the western part of the Democratic Republic of the Congo — though using the vaccine there will require some herculean efforts.

“This is a highly complex, sophisticated operation in one of the most difficult terrains on earth,” Dr. Peter Salama, WHO’s deputy director-general for emergency preparedness and response, said during a news conference in Geneva.

The country’s government still must agree to authorize the vaccine — which has

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks